Position in PFE
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$3,635,983
-$2,715,656 QoQ
Shares Held
150,996
-33.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#732
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Diversified Trust Co holds $139,775,642 across 13 Drug Manufacturers - General names. PFE ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,940 | $35,910,936 | |
| 2 | JNJ |
Johnson & Johnson
|
112,529 | $28,578,989 | |
| 3 | MRK |
Merck & Co., Inc.
|
194,020 | $24,931,570 | |
| 4 | ABBV |
AbbVie Inc.
|
68,165 | $17,153,039 | |
| 5 | AMGN |
Amgen Inc
|
33,837 | $12,253,054 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
55,634 | $7,028,799 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
90,768 | $5,230,051 | |
| 8 | PFE |
Pfizer Inc
This page
|
150,996 | $3,635,983 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,635,983 | 150,996 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $6,351,639 | 226,198 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $3,811,367 | 153,067 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $3,387,081 | 132,931 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $2,709,449 | 111,776 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $2,706,362 | 106,802 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $2,780,821 | 104,818 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $3,284,834 | 113,505 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $2,374,018 | 84,847 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $3,195,661 | 115,159 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $3,020,099 | 104,901 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $3,726,781 | 112,354 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $4,241,124 | 115,625 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $4,891,348 | 119,886 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $5,594,741 | 109,187 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $4,332,020 | 98,995 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $4,836,248 | 92,242 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $4,794,575 | 92,613 | Shares | Sole | 2022-04-07 | |
| 2021-12-31 | $6,222,039 | 105,369 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $4,586,715 | 106,643 | Shares | Sole | 2022-01-13 | |
| 2021-06-30 | $4,415,446 | 112,754 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $3,352,398 | 92,531 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $3,288,605 | 89,340 | Shares | Sole | 2021-01-08 | |
| 2020-09-30 | $3,512,113 | 95,698 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $2,332,166 | 71,320 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $2,239,035 | 68,598 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||